[HTML][HTML] From Immunogen to COVID-19 vaccines: Prospects for the post-pandemic era

G Miao, Z Chen, H Cao, W Wu, X Chu, H Liu… - Biomedicine & …, 2023 - Elsevier
The COVID-19 pandemic has affected millions of people and posed an unprecedented
burden on healthcare systems and economies worldwide since the outbreak of the COVID …

Next-generation COVID-19 vaccines: Opportunities for vaccine development and challenges in tackling COVID-19

Q Li, J Wang, Y Tang, H Lu - Drug Discoveries & Therapeutics, 2021 - jstage.jst.go.jp
The ongoing COVID-19 pandemic, caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has become a global threat. Although non-pharmaceutical …

COVID-19 vaccines: current understanding on immunogenicity, safety, and further considerations

Q He, Q Mao, J Zhang, L Bian, F Gao, J Wang… - Frontiers in …, 2021 - frontiersin.org
The world has entered the second wave of the COVID-19 pandemic, and its intensity is
significantly higher than that of the first wave of early 2020. Many countries or regions have …

A review of the safety and efficacy of current COVID-19 vaccines

Z Huang, Y Su, T Zhang, N Xia - Frontiers of Medicine, 2022 - Springer
Vaccination is the most effective and feasible way to contain the Coronavirus disease 2019
(COVID-19) pandemic. The rapid development of effective COVID-19 vaccines is an …

[HTML][HTML] Inside the story about the research and development of COVID-19 vaccines

SP Patel, GS Patel, JV Suthar - Clinical and Experimental Vaccine …, 2021 - ncbi.nlm.nih.gov
The ongoing coronavirus threat from China has spread rapidly to other nations and has
been declared a global health emergency by the World Health Organization (WHO). The …

A focused review on technologies, mechanisms, safety, and efficacy of available COVID-19 vaccines

P Ghasemiyeh, S Mohammadi-Samani… - International …, 2021 - Elsevier
20 months has been passed since the detection of the first cases of SARS-CoV-2 infection
named COVID-19 from Wuhan city of China. This novel coronavirus spread rapidly around …

[HTML][HTML] Current status of COVID-19 vaccine development: focusing on antigen design and clinical trials on later stages

P Lee, CU Kim, SH Seo, DJ Kim - Immune network, 2021 - ncbi.nlm.nih.gov
The global outbreak of coronavirus disease 2019 (COVID-19) is still threatening human
health, economy, and social life worldwide. As a counteraction for this devastating disease …

Comprehensive narrative review of real-world COVID-19 vaccines: Viewpoints and opportunities

S Liu, M Kang, N Zhao, Y Zhuang, S Li, T Song - Medical Review, 2022 - degruyter.com
Currently, people all over the world have been affected by coronavirus disease 2019
(COVID-19). Fighting against COVID-19 is the top priority for all the countries and nations …

Early approval of COVID-19 vaccines: Pros and cons

MA Rahman, MS Islam - Human Vaccines & Immunotherapeutics, 2021 - Taylor & Francis
The development of safe and effective vaccines has been an overriding priority for
controlling the 2019-coronavirus disease (COVID-19) pandemic. From the onset, COVID-19 …

[HTML][HTML] COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development

R Singh, A Kang, X Luo, M Jeyanathan… - The FASEB …, 2021 - ncbi.nlm.nih.gov
The COVID‐19 pandemic has unfolded to be the most challenging global health crisis in a
century. In 11 months since its first emergence, according to WHO, the causative infectious …